Vessey Rupert

CIK 00016776185 companiesSOMERVILLE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001677618

Recent Transactions

50 trades

Award
Generate Biomedicines, Inc.$GENB
Stock Option (Right to Buy)
2026-02-26+29,561→ 29,561 total
Award
BIO-TECHNE Corp$TECH
Common Stock
2025-10-30+1,640→ 10,987 total
Award
BIO-TECHNE Corp$TECH
Stock Options (Right to Buy)
2025-10-30+3,777→ 3,777 total
Award
BIO-TECHNE Corp$TECH
Common Stock
2024-10-24+1,462→ 9,347 total
Award
BIO-TECHNE Corp$TECH
Stock Options (Right to Buy)
2024-10-24+3,511→ 3,511 total
Award
BIO-TECHNE Corp$TECH
Common Stock
2023-10-26+1,625→ 7,885 total
Award
BIO-TECHNE Corp$TECH
Stock Options (Right to Buy)
2023-10-26+3,937→ 3,937 total
Sale
BRISTOL MYERS SQUIBB CO$BMY
Common Stock, $0.10 par value
2023-05-03$67.06/sh−50,385→ 47,751 total
Other
BRISTOL MYERS SQUIBB CO$BMY
Common Stock, $0.10 par value
2023-03-10+1,373→ 70,169 total
Other
BRISTOL MYERS SQUIBB CO$BMY
Common Stock, $0.10 par value
2023-03-10+231→ 77,496 total
Exercise/Conversion
BRISTOL MYERS SQUIBB CO$BMY
Common Stock, $0.10 par value
2023-03-10+44,541→ 118,263 total
Tax Payment
BRISTOL MYERS SQUIBB CO$BMY
Common Stock, $0.10 par value
2023-03-10$65.71/sh−4,659→ 70,118 total
Exercise/Conversion
BRISTOL MYERS SQUIBB CO$BMY
Common Stock, $0.10 par value
2023-03-10+7,423→ 68,796 total
Tax Payment
BRISTOL MYERS SQUIBB CO$BMY
Common Stock, $0.10 par value
2023-03-10$65.71/sh−4,500→ 65,669 total
Other
BRISTOL MYERS SQUIBB CO$BMY
Common Stock, $0.10 par value
2023-03-10+1,284→ 74,777 total
Exercise/Conversion
BRISTOL MYERS SQUIBB CO$BMY
Common Stock, $0.10 par value
2023-03-10+7,147→ 77,265 total
Tax Payment
BRISTOL MYERS SQUIBB CO$BMY
Common Stock, $0.10 par value
2023-03-10$65.71/sh−3,774→ 73,722 total
Exercise/Conversion
BRISTOL MYERS SQUIBB CO$BMY
Performance Shares
2023-03-10−44,541→ 0 total
Exercise/Conversion
BRISTOL MYERS SQUIBB CO$BMY
Common Stock, $0.10 par value
2023-03-10+7,824→ 73,493 total
Other
BRISTOL MYERS SQUIBB CO$BMY
Common Stock, $0.10 par value
2023-03-10+5,438→ 123,701 total
Exercise/Conversion
BRISTOL MYERS SQUIBB CO$BMY
Market Share Units
2023-03-10−7,147→ 21,442 total
Tax Payment
BRISTOL MYERS SQUIBB CO$BMY
Common Stock, $0.10 par value
2023-03-10$65.71/sh−25,565→ 98,136 total
Exercise/Conversion
BRISTOL MYERS SQUIBB CO$BMY
Market Share Units
2023-03-10−7,824→ 15,651 total
Exercise/Conversion
BRISTOL MYERS SQUIBB CO$BMY
Market Share Units
2023-03-10−7,423→ 7,425 total
Exercise/Conversion
BRISTOL MYERS SQUIBB CO$BMY
Common Stock, $0.10 par value
2022-12-02+8,792→ 65,871 total
Tax Payment
BRISTOL MYERS SQUIBB CO$BMY
Common Stock, $0.10 par value
2022-12-02$81.13/sh−4,498→ 61,373 total
Exercise/Conversion
BRISTOL MYERS SQUIBB CO$BMY
Restricted Stock Units
2022-12-02−8,792→ 8,792 total
Exercise/Conversion
BRISTOL MYERS SQUIBB CO$BMY
Option (right to buy)
2022-11-07−21,288→ 0 total
Sale
BRISTOL MYERS SQUIBB CO$BMY
Common Stock, $0.10 par value
2022-11-07$78.88/sh−45,910→ 57,079 total
Exercise/Conversion
BRISTOL MYERS SQUIBB CO$BMY
Common Stock, $0.10 par value
2022-11-07$47.81/sh+8,491→ 94,498 total
Exercise/Conversion
BRISTOL MYERS SQUIBB CO$BMY
Common Stock, $0.10 par value
2022-11-07$72.42/sh+21,288→ 77,516 total
Exercise/Conversion
BRISTOL MYERS SQUIBB CO$BMY
Common Stock, $0.10 par value
2022-11-07$44.70/sh+8,491→ 86,007 total
Exercise/Conversion
BRISTOL MYERS SQUIBB CO$BMY
Common Stock, $0.10 par value
2022-11-07$38.41/sh+8,491→ 102,989 total
Exercise/Conversion
BRISTOL MYERS SQUIBB CO$BMY
Common Stock, $0.10 par value
2022-11-07$70.89/sh+5,843→ 56,228 total
Exercise/Conversion
BRISTOL MYERS SQUIBB CO$BMY
Option (right to buy)
2022-11-07−8,491→ 0 total
Exercise/Conversion
BRISTOL MYERS SQUIBB CO$BMY
Option (right to buy)
2022-11-07−5,843→ 0 total
Exercise/Conversion
BRISTOL MYERS SQUIBB CO$BMY
Option (right to buy)
2022-11-07−8,491→ 0 total
Exercise/Conversion
BRISTOL MYERS SQUIBB CO$BMY
Option (right to buy)
2022-11-07−8,491→ 0 total
Award
BIO-TECHNE Corp$TECH
Stock Options (Right to Buy)
2022-10-27+865→ 865 total
Award
BIO-TECHNE Corp$TECH
Common Stock
2022-10-27+338→ 1,565 total
Exercise/Conversion
BRISTOL MYERS SQUIBB CO$BMY
Option (right to buy)
2022-03-16−12,233→ 0 total
Sale
BRISTOL MYERS SQUIBB CO$BMY
Common Stock, $0.10 par value
2022-03-16$69.27/sh−31,331→ 46,308 total
Sale
BRISTOL MYERS SQUIBB CO$BMY
Common Stock, $0.10 par value
2022-03-16$69.23/sh−43,228→ 50,385 total
Exercise/Conversion
BRISTOL MYERS SQUIBB CO$BMY
Common Stock, $0.10 par value
2022-03-16$55.52/sh+5,294→ 72,890 total
Exercise/Conversion
BRISTOL MYERS SQUIBB CO$BMY
Option (right to buy)
2022-03-16−21,288→ 0 total
Exercise/Conversion
BRISTOL MYERS SQUIBB CO$BMY
Option (right to buy)
2022-03-16−5,294→ 0 total
Exercise/Conversion
BRISTOL MYERS SQUIBB CO$BMY
Common Stock, $0.10 par value
2022-03-16$38.41/sh+8,490→ 93,613 total
Exercise/Conversion
BRISTOL MYERS SQUIBB CO$BMY
Common Stock, $0.10 par value
2022-03-16$54.29/sh+12,233→ 85,123 total
Exercise/Conversion
BRISTOL MYERS SQUIBB CO$BMY
Common Stock, $0.10 par value
2022-03-16$66.35/sh+21,288→ 67,596 total
Exercise/Conversion
BRISTOL MYERS SQUIBB CO$BMY
Option (right to buy)
2022-03-16−8,490→ 8,491 total

Companies

Recent Filings

Address

GENERATE BIOMEDICINES, INC. 101 SOUTH STREET, SUITE 900

SOMERVILLE, MA, 02143

View on SEC.gov